ホーム › 慢性リンパ性白血病 › コロンビア特別区 › Washington
Washington、DCにおける慢性リンパ性白血病の臨床試験
Washingtonとその周辺地域（約30マイル以内）の拠点で、慢性リンパ性白血病に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
被験者募集中第1/2相
- American Oncology Partners of Maryland Pa, Bethesda · 7マイル先
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
被験者募集中第3相
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7マイル先
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
被験者募集中第3相
- GC2202 Study Site 111, Bethesda · 7マイル先
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
被験者募集中第3相
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
被験者募集中第3相
- American Oncology Partners of Maryland Pa, Bethesda · 7マイル先
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
被験者募集中第3相
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
被験者募集中第2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
被験者募集中第3相
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7マイル先
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
被験者募集中第2相
- Maryland Oncology Hematology, Silver Spring · 7マイル先
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
被験者募集中早期第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
被験者募集中第3相
- American Oncology Partners of Maryland, PA, Bethesda · 7マイル先
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
被験者募集中第3相
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7マイル先
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
被験者募集中第1相
- National Institute of Health, Bethesda · 7マイル先
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
被験者募集中第2相
- American Oncology Partners, PA, Bethesda · 7マイル先
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
被験者募集中観察研究健康なボランティア歓迎
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
被験者募集中第3相
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7マイル先
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7マイル先
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
他の都市における慢性リンパ性白血病の試験
- Boston, MA31件の研究
- Columbus, OH28件の研究
- Durham, NC27件の研究
- Seattle, WA20件の研究
- New York City, NY18件の研究
- Rochester, MN18件の研究
- Houston, TX17件の研究
- Baldwin Park, CA16件の研究
- Milwaukee, WI15件の研究
- Chicago, IL14件の研究
- Cincinnati, OH14件の研究
- Nashville, TN13件の研究
Washingtonにおける他の研究
- がん（全種類）58件の研究
- 非小細胞肺癌55件の研究
- 乳がん46件の研究
- 転移性癌43件の研究
- 肺がん41件の研究
- 前立腺がん38件の研究
- 肥満症33件の研究
- 大腸癌29件の研究
- 心血管疾患28件の研究
- 膀胱癌26件の研究
- 急性骨髄性白血病24件の研究
- 卵巣がん23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。